Peripartum cardiomyopathy

MC Honigberg, MM Givertz - Bmj, 2019 - bmj.com
Peripartum cardiomyopathy (PPCM) is a rare, often dilated, cardiomyopathy with systolic
dysfunction that presents in late pregnancy or, more commonly, the early postpartum period …

[HTML][HTML] The interplay between prolactin and cardiovascular disease

A Glezer, MR Santana, MD Bronstein… - Frontiers in …, 2023 - frontiersin.org
Hyperprolactinemia can be caused by several conditions and its effects on the hypothalamic-
pituitary-gonadal axis are understood in more detail. Nevertheless, in recent decades, other …

2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during …

V Regitz-Zagrosek, JW Roos-Hesselink… - European heart …, 2018 - academic.oup.com
not override in any way whatsoever the individual responsibility of health professionals to
make appropriate and accurate decisions in consideration of each patient's health condition …

Detecting cardiomyopathies in pregnancy and the postpartum period with an electrocardiogram-based deep learning model

DA Adedinsewo, PW Johnson… - … Heart Journal-Digital …, 2021 - academic.oup.com
Aims Cardiovascular disease is a major threat to maternal health, with cardiomyopathy
being among the most common acquired cardiovascular diseases during pregnancy and the …

[HTML][HTML] Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis

D Duncker, R Westenfeld, T Konrad, T Pfeffer… - Clinical Research in …, 2017 - Springer
Introduction Peripartum cardiomyopathy (PPCM) is a rare cardiomyopathy characterized by
an acute reduction in left ventricular ejection fraction (LVEF). Sudden deaths during the …

The wearable cardioverter-defibrillator: current technology and evolving indications

S Reek, H Burri, PR Roberts, C Perings, AE Epstein… - Europace, 2017 - academic.oup.com
The wearable cardioverter-defibrillator has been available for over a decade and now is
frequently prescribed for patients deemed at high arrhythmic risk in whom the underlying …

Cardioprotective actions of relaxin

B Martin, G Romero, G Salama - Molecular and Cellular Endocrinology, 2019 - Elsevier
Relaxin is a hormone of pregnancy first discovered for its ability to induce ligament
relaxation in nonpregnant guinea pig and is important for softening of the birth canal during …

Burden of arrhythmias in peripartum cardiomyopathy: analysis of 9841 hospitalizations

S Mallikethi-Reddy, E Akintoye, N Trehan… - International journal of …, 2017 - Elsevier
Background Peripartum cardiomyopathy (PPCM) is associated with significant morbidity and
mortality. Arrhythmogenic causes of death have been implicated in a significant number of …

Peripartum cardiomyopathy: risks diagnosis and management

S Carlson, J Schultz, B Ramu… - Journal of Multidisciplinary …, 2023 - Taylor & Francis
Peripartum cardiomyopathy is a rare cause of heart failure that occurs during late pregnancy
or in the early postpartum period. Delays in diagnosis may occur as symptoms of heart …

[HTML][HTML] A contemporary review of peripartum cardiomyopathy

PA Patel, A Roy, R Javid, JAW Dalton - Clinical Medicine, 2017 - Elsevier
Peripartum cardiomyopathy reflects the presence of cardiac failure in the absence of
determinable heart disease and occurs in late third trimester of pregnancy or up to 6 months …